Watson Pharmaceuticals Launch Losartan and Losartan Co tablets in South Africa

Watson Pharmaceuticals launched the brands “HYTENZA” and “HYTENZA CO” (Losartan 50mg, 100mg tablets and Losartan plus Hydrochlorothiazide 50mg/12,5mg, 100mg/25mg) in South Africa on 26th June 2012. The product was developed and registered through ABEX and licensed to Watson Pharma under a distribution agreement.